Viewing Study NCT02742766


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2026-02-21 @ 8:11 PM
Study NCT ID: NCT02742766
Status: COMPLETED
Last Update Posted: 2019-07-24
First Post: 2016-03-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose escalation study View
None Safety View
None Pharmacodynamics View
None Pharmacokinetics View
None GSK3008356 View
None Tolerability View